Radiation study for localized prostate cancer using a focused beam
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether a precise type of radiation (called stereotactic body radiotherapy) can treat localized prostate cancer. It may help people who fit certain cancer stage and health criteria get treatment planning tailored to them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by a biopsy (prostate adenocarcinoma).
- Your cancer stage is localized to the prostate area (about Stage I to IV), with no confirmed spread to distant sites.
- You may need recent scans (exam, CT, MRI, and possibly a bone scan) to check whether it has spread.
- Your prostate size is not larger than 100 cc (and it’s measured on CT or ultrasound).
- You are able to do normal activities (ECOG 0–1, meaning not very limited).
- You must agree to take part, including signing consent and completing study questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether adding a stronger “boost” dose of targeted radiation (SBRT) can better control higher-risk prostate cancer. It may help by increasing radiation coverage to the prostate while trying to limit treatment to surrounding areas.
This trial tests a new radiation technique to better protect erectile function during prostate cancer treatment. It uses advanced imaging to precisely target the tumor while reducing harm to nearby structures.
This Phase 2 study tests a focused radiation approach using stereotactic body radiation therapy (SBRT) for people with one prostate tumor visible on imaging. It aims to treat a single tumor area while limiting treatment to the rest of the prostate.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This trial tests a radiation approach that delivers treatment in a small number of larger “fractions” (short-course SBRT) for prostate cancer. It may help by targeting the prostate while shortening the overall number of visits.
This early-phase study tests a prostate radiation approach given in two treatments, planned using MRI. It’s designed for men with lower-to-intermediate risk prostate cancer and aims to see if this method is safe and works well.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.